Georgia Tech Leads $16M Zinc Finger Studies

Researchers will use zinc finger nuclease and DNA correction technologies to try to reverse sickle cell disease, a single-gene disorder.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.